Concert Pharmaceuticals Inc. (CNCE) Fell -5.58% or -0.83 To Price $14.13 On Thursday


Concert Pharmaceuticals Inc. (CNCE) fell -5.58% or -0.83 to $14.13. It is about 80160 shares traded, which is 66.54% compare to the average total volume 120474. The market cap of CNCE is $330.97 million. The year to date change is -50.6%. The 52 week price range is from $13.57 to $30.71. Price of CNCE have changed -4.89% during last week. It have changed -11.58% over last month, -20.50% over last 3 months, -31.83% over last 6 months and -1.45% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 16.52. It is 16.91% above current price. The 200-day Moving Averages for CNCE is 20.34. It is 43.95% above current price. The 52-week High is 30.71. It is 117.34% from the current price. The 52-week Low is 13.57. It is -3.96% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 4.98 on 2018-08-15. Short % to float is 3.13%. There are some statistics of CNCE. It is has market cap $330.97 million. The share outstanding is 23.42 million. The average volume is 120474. The revenue is 143.84M. The percent of top 15 Institution holding is 68.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 78.75%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 63.32%.


Tags:

Share this post